U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 60

Tests names and labsConditionsGenes, analytes, and microbesMethods

Spinocerebellar ataxia 1, 164400, Autosomal dominant (Spinocerebellar ataxia type 1) (ATXN1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Spinocerebellar Ataxia Panel

Mayo Clinic Laboratories Mayo Clinic
United States
55
  • T Targeted variant analysis

Spinocerebellar Ataxia Type 1

Institute of Human Genetics Justus-Liebig University
Germany
11
  • E Sequence analysis of select exons

Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7)

Center for Genetics at Saint Francis Saint Francis Hospital
United States
55
  • T Targeted variant analysis

SCA Panel (SCA1, 2, 3, 6, 7) test

Neurogenetics Cyprus Institute of Neurology and Genetics
Cyprus
55
  • T Targeted variant analysis

Ataxin 1 (ATXN1) gene CAG triplet repeat test

Neurogenetics Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

ATXN1 - Repeat expansion analysis

Centogene AG - the Rare Disease Company
Germany
11
  • T Targeted variant analysis

Ataxia / Spastic Paraplegia Comprehensive Panel

Centogene AG - the Rare Disease Company
Germany
451452
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia Repeat Expansion Panel

Centogene AG - the Rare Disease Company
Germany
1313
  • T Targeted variant analysis

Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 16 loci)

Variantyx, Inc.
United States
1513
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci)

Variantyx, Inc.
United States
5253
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Spinocerebellar ataxia type 12 presymptomatic testing

Genetics Service Unit BRIC-National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 12

Genetics Service Unit BRIC-National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 1 presymptomatic testing

Genetics Service Unit BRIC-National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Ataxia Repeat Expansion Panel

Genetic Services Laboratory University of Chicago
United States
1414
  • X Mutation scanning of select exons

Ataxia Exome

Genetic Services Laboratory University of Chicago
United States
294481
  • C Sequence analysis of the entire coding region

Spinocerebellar ataxia type 1

Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba
Canada
11
  • T Targeted variant analysis

Spinocerebellar ataxia 1 (SCA1, CAG expansion on ATXN1 gene)

CGC Genetics Unilabs
Portugal
11
  • T Targeted variant analysis

Spinocerebellar Ataxia & Related Disorders Panel

GeneDx
United States
256
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Genetic Test for Spinocerebellar Ataxias - SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 and DRPLA

CGPP - Center for Predictive and Preventive Genetics IBMC - Institute for Cell and Molecular Biology
Portugal
77
  • D Deletion/duplication analysis

Results: 1 to 20 of 60

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.